FILE:COV/COV-8K-20080516084934.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
 
 
 
 
 
On May 16, 2008, Covidien Ltd. (the "Company") and Covidien International Finance S.A. ("CIFSA") issued a press release announcing that they have commenced a registered exchange offer for CIFSA's $250,000,000 5.150% Senior Notes due 2010, $500,000,000 5.450% Senior Notes due 2012, $1,150,000,000 6.000% Senior Notes due 2017 and $850,000,000 6.550% Senior Notes due 2037. The press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: May 16, 2008
 

Exhibit 99.1
HAMILTON, Bermuda  May 16, 2008  Covidien Ltd. (NYSE: COV, BSX: COV) and Covidien International Finance S.A. ("CIFSA") today announced that they have commenced a registered exchange offer to exchange up to $250,000,000 of CIFSA's newly registered 5.150% Senior Notes due 2010 (the "New 2010 Notes") for an equal amount of its privately placed 5.150% Senior Notes due 2010 (the "Outstanding 2010 Notes"), exchange up to $500,000,000 of CIFSA's newly registered 5.450% Senior Notes due 2012 (the "New 2012 Notes") for an equal amount of its privately placed 5.450% Senior Notes due 2012 (the "Outstanding 2012 Notes"), exchange up to $1,150,000,000 of CIFSA's newly registered 6.000% Senior Notes due 2017 (the "New 2017 Notes") for an equal amount of its privately placed 6.000% Senior Notes due 2017 (the "Outstanding 2017 Notes"), and exchange up to $850,000,000 of CIFSA's newly registered 6.550% Senior Notes due 2037 (the "New 2037 Notes" and, together with the New 2010 Notes, the New 2012 Notes and the New 2017 Notes, the "New Notes") for an equal amount of its privately placed 6.550% Senior Notes due 2037 (the "Outstanding 2037 Notes" and, together with the Outstanding 2010 Notes, the Outstanding 2012 Notes and Outstanding 2017 Notes, the "Outstanding Notes"). The New Notes will be fully and unconditionally guaranteed by Covidien and are substantially identical to the Outstanding Notes, except that the New Notes have been registered under the Securities Act of 1933, as amended, and certain transfer restrictions, registration rights and additional interest provisions relating to the Outstanding Notes do not apply to the New Notes.
Covidien and CIFSA will accept for exchange any and all Outstanding Notes validly tendered and not withdrawn prior to the expiration of the exchange offer at 5:00 p.m., New York City time, on June 16, 2008, unless extended.
The terms of the exchange offer and other information relating to Covidien and CIFSA are set forth in a prospectus dated May 16, 2008. Copies of the prospectus and the related letters of transmittal may be obtained from Deutsche Bank Trust Company Americas, which is serving as the exchange agent for the exchange offer.
The address, email, telephone and facsimile number of Deutsche Bank Trust Company Americas are as follows:
Deutsche Bank Trust Company Americas
By Mail:
DB Services Tennessee, Inc.
Reorganization Unit
P.O. Box 305050
Nashville, TN 37230
By Overnight Mail or Courier:
DB Services Tennessee, Inc.
Trust and Securities Services
Reorganization Unit
648 Grassmere Park Road
Nashville, TN 37211
Email:
SPU-Reorg.Operations@db.com
Information: (800) 735-7777
Fax: (615) 835-3701
This announcement does not constitute an offer to sell or the solicitation of offers to buy or exchange the New Notes or the Outstanding Notes. The exchange offer is made solely pursuant to the prospectus dated May 16, 2008, including any supplements thereto.


